Table 3.
Characteristics of Analytical Population 40 to 75 Years Old, by Sex
| Total | Men | Women | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Size | % | 95% CI | Sample Size | % | 95% CI | Sample Size | % | 95% CI | ||||
| Total | 1975 | 100.0 | — | — | 950 | 47.9 | 46.8 | 49.0 | 1025 | 52.1 | 51.0 | 53.2 |
| Age group | ||||||||||||
| 40 to 59 y | 1175 | 71.4 | 69.8 | 73.0 | 566 | 73.0 | 71.1 | 74.9 | 609 | 69.9 | 67.9 | 71.8 |
| 60 to 75 y | 905 | 28.6 | 27.0 | 30.2 | 384 | 27.0 | 25.1 | 28.9 | 416 | 30.1 | 28.2 | 32.1 |
| Secondary school graduation and higher | 1692 | 83.6 | 80.5 | 86.3 | 806 | 80.8 | 75.4 | 85.2 | 886 | 86.3 | 82.6 | 89.3 |
| Daily or occasional smoker | 347 | 21.5 | 18.3 | 25.0 | 171 | 21.2 | 16.5 | 26.8 | 176 | 21.7 | 17.6 | 26.4 |
| Diabetes | 172 | 8.7 | 6.6 | 11.5 | 88 | 10.3* | 7.2 | 14.5 | 84 | 7.3 | 5.2 | 10.1 |
| Chronic kidney disease | 117 | 4.5 | 3.4 | 5.9 | 44 | 3.3* | 2.3 | 4.8 | 73 | 5.5* | 3.9 | 7.9 |
| Hypertensive | 677 | 29.0 | 26.3 | 32.0 | 341 | 30.2 | 25.3 | 35.7 | 336 | 28.0 | 24.7 | 31.5 |
| Antihypertensive medication use | 582 | 25.9 | 23.2 | 28.8 | 286 | 26.7 | 21.9 | 32.2 | 296 | 25.2 | 21.9 | 28.7 |
| Family history of CVD at age ≤60 y | 431 | 20.4 | 17.8 | 23.2 | 186 | 17.4 | 13.9 | 21.5 | 245 | 23.1 | 19.9 | 26.7 |
| LDL cholesterol level ≥3.5 mmol/L | 980 | 47.3 | 43.2 | 51.3 | 520 | 50.9 | 45.0 | 56.8 | 460 | 43.9 | 40.2 | 47.6 |
| Statin medication use | 301 | 13.0 | 10.7 | 15.6 | 167 | 15.0 | 11.5 | 19.4 | 134 | 11.1 | 9.0 | 13.8 |
Source: Combined 2007–2009 and 2009–2011 Canadian Health Measures Survey.
CI indicates confidence interval; CVD, cardiovascular disease; LDL, low-density lipoprotein.
*
Use with caution (coefficient of variation 16.6% to 33.3%).